Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicorandil vs atorvastatin for prevention of contrast-induced nephropathy in patients with normal renal function
IRCT20150808023559N22Phase 2Completed
- Sponsor
- Ardabil University of Medical Sciences
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in contrast-induced nephropathy (CIN) comparing Nicorandil pretreatment with Atorvastatin pretreatment (2 arms). Primary endpoint: Incidence of contrast-induced nephropathy. Started Jul 2020; status: completed.
02
Drugs
nicorandilatorvastatin
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on IRCT20150808023559N22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150808023559N22.